Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa
Stefan Heitmeier, Mayken Visser, Adrian Tersteegen, Julia Dietze‐Torres, Julia Glunz, Christoph Gerdes, Volker Laux, Jan Stampfuss, Susanne Roehrig
Topics & Concepts
AntithromboticPharmacologyThrombusAspirinPartial thromboplastin timeHemostasisBleeding timeThrombinCoagulationActivated clotting timeMedicineChemistryAnticoagulantPlateletInternal medicinePlatelet aggregationCoagulation, Bradykinin, Polyphosphates, and AngioedemaBlood Coagulation and Thrombosis MechanismsVitamin K Research Studies